KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Exchange Rate Effect (2016 - 2026)

Medtronic (MDT) has disclosed Exchange Rate Effect for 13 consecutive years, with $24.0 million as the latest value for Q1 2026.

  • Quarterly Exchange Rate Effect rose 118.46% to $24.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $335.0 million through Jan 2026, up 316.13% year-over-year, with the annual reading at $188.0 million for FY2025, 181.74% up from the prior year.
  • Exchange Rate Effect hit $24.0 million in Q1 2026 for Medtronic, up from -$39.0 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $540.0 million in Q1 2023 to a low of -$175.0 million in Q4 2023.
  • Historically, Exchange Rate Effect has averaged $4.3 million across 5 years, with a median of -$39.0 million in 2023.
  • Biggest five-year swings in Exchange Rate Effect: soared 1600.0% in 2023 and later crashed 1075.0% in 2025.
  • Year by year, Exchange Rate Effect stood at -$101.0 million in 2022, then plummeted by 73.27% to -$175.0 million in 2023, then skyrocketed by 102.29% to $4.0 million in 2024, then plummeted by 1075.0% to -$39.0 million in 2025, then soared by 161.54% to $24.0 million in 2026.
  • Business Quant data shows Exchange Rate Effect for MDT at $24.0 million in Q1 2026, -$39.0 million in Q4 2025, and $67.0 million in Q3 2025.